PLTT

Pilot Therapeutics Holdings Inc. Stock Price

OTCPK:PLTT Community·US$1.2k Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

PLTT Share Price Performance

US$0
0.00 (0.00%)
US$0
0.00 (0.00%)
Price US$0

PLTT Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Weak fundamentals or lack of information.

3 Risks
0 Rewards

Pilot Therapeutics Holdings Inc. Key Details

US$0

Revenue

US$0

Cost of Revenue

US$0

Gross Profit

US$6.3m

Other Expenses

-US$6.3m

Earnings

Last Reported Earnings
Jun 30, 2003
Next Reporting Earnings
n/a
0
0%
0%
0%
View Full Analysis

About PLTT

Founded
1998
Employees
n/a
CEO
Ross Consaul
Website
n/a

Pilot Therapeutics Holdings Inc. develops and manufactures pharmaceutical products for treatment of dysfunctional lipid metabolism. The company offers Airozin for asthma, PLT 1288 for arthritis, PLT 732 for cardiovascular disease and diabetes, and PLT 2753 for allergic rhinitis. Additionally, it provides clinical trials, personnel recruitment, sales and marketing, and raising capital services. Pilot Therapeutics Holdings Inc. was founded in 1998 and is based in the United States.

Recent PLTT News & Updates

No updates

Recent updates

No updates